Moore Capital Management, LP Grifols Sa Transaction History

Moore Capital Management, LP

  • $5.25 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$16.28 - $25.63 $2.37 Million - $3.73 Million
-145,396 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$19.57 - $23.52 $1.95 Million - $2.35 Million
-99,802 Reduced 40.7%
145,396 $3.39 Million
Q3 2019

Nov 14, 2019
BUY
$19.85 - $22.76 $4.87 Million - $5.58 Million
245,198 New
245,198 $4.91 Million

Others Institutions Holding GRFS

# of Institutions
147
Shares Held
151M
Call Options Held
2.38M
Put Options Held
662K
View Full List

About Grifols SA

GRFS Quotes by TradingView
  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $6.06B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Moore Capital Management, LP Portfolio

Follow Moore Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email